Nutriband (NASDAQ:NTRB – Get Free Report) will likely be announcing its earnings results before the market opens on Tuesday, April 29th. Analysts expect the company to announce earnings of ($0.12) per share and revenue of $0.71 million for the quarter.
Nutriband Stock Up 1.4 %
Shares of NTRB stock opened at $5.12 on Tuesday. The company has a market capitalization of $56.86 million, a price-to-earnings ratio of -7.21 and a beta of 1.19. Nutriband has a 12-month low of $3.20 and a 12-month high of $11.78. The firm has a fifty day moving average of $6.23 and a 200-day moving average of $5.78. The company has a quick ratio of 4.83, a current ratio of 4.96 and a debt-to-equity ratio of 0.01.
Analyst Ratings Changes
Separately, Noble Financial started coverage on Nutriband in a research report on Wednesday, January 22nd. They set an “outperform” rating and a $13.00 price objective for the company.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
See Also
- Five stocks we like better than Nutriband
- Best Stocks Under $10.00
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- Dividend Capture Strategy: What You Need to Know
- Why Call Option Traders Are Targeting This Dividend ETF Now
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
